Check out the companies that are trending in pre-market trading. Alphabet — The YouTube and Google owner rose more than 4% after Warren Buffett’s Berkshire Hathaway revealed it acquired more than $4 billion in Alphabet stock in the third quarter. Zymeworks and Jazz Pharmaceuticals — Pharmaceutical companies Zymeworks and Jazz Pharmaceuticals have reported Phase 3 trial results for their cancer drug Ziihera. Zymeworks stock rose about 35%, while Jazz rose nearly 21%. Lithium Stocks — Citing local news sources in China, Bloomberg reported that Ganfeng Lithium Group Company Chairman Li Liangbin said on Sunday that lithium demand is expected to increase by 30% in 2026. Albemarle, the largest U.S. producer, rose 4%. Sigma Lithium soared 26%. Lithium Argentina and Lithium America rose about 8% and 3%, respectively. Quantum Computing — Stocks rose 21% after the quantum computing provider announced a strategic roadmap for scalable quantum and photonic manufacturing. Clearwater Analytics Holdings — Shares rose 10% on speculation that Clearwater was considering a deal to go private. Bloomberg reported late Friday that Warbug Pincus and Permira were in talks to buy the investment and accounting software maker. Alibaba — E-commerce giant Alibaba unveiled Qwen App, an improved chat GPT-like artificial intelligence application, in China, pushing its stock price up 2.5%. Gap — The apparel retailer added nearly 3% on the back of Barclays’ upgrade from evenweight to overweight. The bank said Gap has carried out a disciplined turnaround and should see a sustained brand recovery. Apple — Investors reacted to Friday’s report in the Financial Times that Apple is preparing to identify and name a successor to CEO Tim Cook. Apple fell 1%. Xpeng — U.S.-listed shares fell nearly 4% after the Chinese electric car maker reported mixed third-quarter results, with an adjusted loss narrower than analysts polled by FactSet expected and revenue roughly in line with expectations. Fourth-quarter earnings guidance was below consensus expectations. Aramark — The food service provider fell 7% after fiscal fourth-quarter adjusted earnings of 57 cents, below the 64 cents expected by analysts surveyed by FactSet. Aramark’s sales of $5.05 billion also fell short of the consensus of $5.16 billion. Aramark’s adjusted earnings per share for the fiscal year ending September 2026 is expected to be between $2.18 and $2.28, compared with analyst estimates of $2.27. — CNBC’s Michelle Fox-Theobald, Fred Imbert, Sean Conlon, Alex Harring and Lisa Han contributed reporting.
